• Journal Article

Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an In vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B

Citation

Lu, D. M., Garcia-Contreras, L., Xu, D., Kurtz, S. L., Liu, J., Braunstein, M., ... Hickey, A. (2007). Poly (lactide-co-glycolide) microspheres in respirable sizes enhance an In vitro T cell response to recombinant Mycobacterium tuberculosis antigen 85B. Pharmaceutical Research, 24(10), 1834-1843. DOI: 10.1007/s11095-007-9302-8

Abstract

Purpose. To investigate the use of poly (lactide-co-glycolide) (PLGA) microparticles in respirable sizes as carriers for Antigen 85B (Ag85B), a secreted protein of Mycobacterium tuberculosis, with the ultimate goal of employing them in pulmonary delivery of tuberculosis vaccine. Materials and Methods. Recombinant Ag85B was expressed from two Escherichia coli strains and encapsulated by spray-drying in PLGA microspheres with/without adjuvants. These microspheres containing rAg85B were assessed for their ability to deliver antigen to macrophages for subsequent processing and presentation to the specific CD4 T-hybridoma cells DB-1. DB-1 cells recognize the Ag85B(97-112) epitope presented in the context of MHC class II and secrete IL-2 as the cytokine marker. Results. Microspheres suitable for aerosol delivery to the lungs (3.4-4.3 mu m median diameter) and targeting alveolar macrophages were manufactured. THP-1 macrophage-like cells exposed with PLGA-rAg85B microspheres induced the DB-1 cells to produce IL-2 at a level that was two orders of magnitude larger than the response elicited by soluble rAg85B. This formulation demonstrated extended epitope presentation. Conclusions. PLGA microspheres in respirable sizes were effective in delivering rAg85B in an immunologically relevant manner to macrophages. These results are a foundation for further investigation into the potential use of PLGA particles for delivery of vaccines to prevent M. tuberculosis infection